FDA Alerts

Hepatitis C
Hepatitis C
FDA Roundup: New Options for Hepatitis C, PAD, Nausea
10/14/2014
Primary care practitioners should be aware of new FDA approvals for treating hepatitis C, peripheral artery disease, and chemotherapy-related nausea.
10/14/2014
FDA Alerts
FDA Alerts
FDA approves expanded use of constipation drug
09/30/2014
By...
09/30/2014
FDA
FDA
FDA Round-Up: New Options for COPD, Melanoma, Crohn's Disease
09/28/2014
Primary care practitioners should be aware of new FDA approvals that may be useful when treating patients with COPD, melanoma, and Crohn's disease.
09/28/2014
Diabetes Q&A
Diabetes Q&A
FDA Approves New Diabetes Drug to Control Blood Sugar
09/22/2014
The FDA has approved Trulicity, a new injection for glycemic control in patients with type 2 diabetes.
09/22/2014
Endocrine system
Endocrine system
FDA Restricts Age-Related Testosterone Drug Use
09/18/2014
An advisory panel of experts from the FDA voted to restrict the use of testosterone drugs among men with low-hormone levels.
09/18/2014
Obesity
Obesity
FDA Advisory Panel: Obesity and Hypoparathyroidism Drugs Receive Nod of Approval
09/15/2014
The FDA has approved several new drugs that medical professionals should be aware of.
09/15/2014
FDA
FDA
FDA Round-Up: New Weight Loss Drug Approved, Polypill Efficacy in Review
09/12/2014
The FDA has approved a new weight-loss drug, but is still uncertain how to best make use of newly proposed "polypills."
09/12/2014
Hormone Therapy
Hormone Therapy
Hormone replacement therapy Natpara appears effective: FDA review
09/11/2014
NPS Pharmaceuticals Inc's hormone replacement therapy Natpara appears effective, though data from one clinical trial site was excluded due to manufacturing violations, according to a preliminary report...
09/11/2014
Kidney Disease
Kidney Disease
FDA Approved Test to Predict Acute Kidney Injury
09/08/2014
A new test uses protein detected in the urine to accurately predict the risk of acute kidney injury.
09/08/2014
Melanoma
Melanoma
FDA Approves Drug to Treat Advanced Melanoma
09/05/2014
The FDA has approved pembrolizumab (Keytruda) for the treatment of advanced or unresectable melanoma in patients that are no longer responding to other drugs.
09/05/2014